Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03980574 · ClinicalTrials.gov registry record · NA

Dietary Supplementation in Heart Failure

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03980574: Completed NA study, sponsored by Ohio State University.

NCT03980574 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03980574, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

A single-center, double-blind, placebo-controlled, cross-over study pilot study comparing R Drink vs. placebo in 60 heart failure patients. Half of the participants will also have diabetes mellitus. The 60 patients will be distributed among three arms. Total distance walked in six minutes and hospital readmission rates will be examined. Eligible heart failure patients include those with systolic or diastolic heart failure and diabetes mellitus can be Type I or II. All patients will continue on their standard heart failure and diabetes therapies while they participate in the study.

Primary Outcome

Number of total hospital readmissions post-enrollment.

Interventions

  • DIETARY_SUPPLEMENT R Drink

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-04-01
Est. Completion 2020-06-29
Phase NA
Ohio State University

552 total trials

What the finished NCT03980574 record still lists

NCT03980574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which R Drink is the first listed.

NCT03980574 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03980574 about?

NCT03980574 is a clinical study titled "Dietary Supplementation in Heart Failure". A single-center, double-blind, placebo-controlled, cross-over study pilot study comparing R Drink vs. placebo in 60 heart failure patients. Half of the participants will also have diabetes mellitus. The 60 patients will be distributed among three arms. Total distance walked in six minutes and hospit...

What is the current status of trial NCT03980574?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-04-01. Estimated completion is 2020-06-29.

What interventions are being tested in trial NCT03980574?

The interventions under investigation include: R Drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03980574?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03980574's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03980574, the US trial registry maintained by the National Library of Medicine. NCT03980574 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.